|
1
|
Guariguata L, Whiting DR, Hambleton I,
Beagley J, Linnenkamp U and Shaw JE: Global estimates of diabetes
prevalence for 2013 and projections for 2035. Diabetes Res Clin
Pract. 103:137–149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ahlqvist E, Van Zuydam NR, Groop LC and
McCarthy MI: The genetics of diabetic complications. Nat Rev
Nephrol. 11:277–287. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Donate-Correa J, Martín-Núñez E,
Muros-de-Fuentes M, Mora-Fernández C and Navarro-González JF:
Inflammatory cytokines in diabetic nephropathy. Zhong Hua Tang Niao
Bing Za Zhi. 2015:9484172015.
|
|
4
|
Lim AKH: Diabetic
nephropathy-complications and treatment. Int J Nephrol Renovasc
Dis. 7:361–381. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
You H, Gao T, Cooper TK, Morris SM Jr and
Awad AS: Arginase inhibition: A new treatment for preventing
progression of established diabetic nephropathy. Am J Physiol Renal
Physiol. 309:F447–F455. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yeung ML, Yao Y, Jia L, Chan JF, Chan KH,
Cheung KF, Chen H, Poon VK, Tsang AK, To KK, et al: MERS
coronavirus induces apoptosis in kidney and lung by upregulating
Smad7 and FGF2. Nat Microbiol. 1:160042016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Isermann B, Vinnikov IA, Madhusudhan T,
Herzog S, Kashif M, Blautzik J, Corat MA, Zeier M, Blessing E, Oh
J, et al: Activated protein C protects against diabetic nephropathy
by inhibiting endothelial and podocyte apoptosis. Nat Med.
13:1349–1358. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nong Q, Li S, Wu Y and Liu D: LncRNA
COL1A2-AS1 inhibits the scar fibroblasts proliferation via
regulating miR-21/Smad7 pathway. Biochem Biophys Res Commun.
495:319–324. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu J and Xu Y: The lncRNA MEG3
downregulation leads to osteoarthritis progression via miR-16/SMAD7
axis. Cell Biosci. 7:692017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu TM, Palanisamy K, Sun KT, Day YJ, Shu
KH, Wang IK, Shyu WC, Chen P, Chen YL and Li CY: RANTES mediates
kidney ischemia reperfusion injury through a possible role of
HIF-1α and LncRNA PRINS. Sci Rep. 6:184242016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Szegedi K, Sonkoly E, Nagy N, Németh IB,
Bata-Csörgo Z, Kemény L, Dobozy A and Széll M: The anti-apoptotic
protein G1P3 is overexpressed in psoriasis and regulated by the
non-coding RNA, PRINS. Exp Dermatol. 19:269–278. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chinese Medical Association for Diabetes
Mellitus, a Group of Microvascular Complications, . China expert
consensus for the prevention and treatment of diabetic nephropathy
(2014 edition). Chin J Diabetes. 6:792–801. 2014.(In Chinese).
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zou XF, Song B, Duan JH, Hu ZD, Cui ZL and
Yang T: PRINS Long Noncoding RNA involved in IP-10 mediated
allograft rejection in rat kidney transplant. Transplant Proc.
50:1558–1565. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao XY and Lin JD: Long noncoding RNAs: A
new regulatory code in metabolic control. Trends Biochem Sci.
40:586–596. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kornfeld JW and Brüning JC: Regulation of
metabolism by long, non-coding RNAs. Front Genet. 5:572014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Carter G, Miladinovic B, Patel AA, Deland
L, Mastorides S and Patel NA: Circulating long noncoding RNA GAS5
levels are correlated to prevalence of type 2 diabetes mellitus.
BBA Clin. 4:102–107. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lan HY: Smad7 as a therapeutic agent for
chronic kidney diseases. Front Biosci. 13:4984–4992. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dai XY, Zhou L, Huang XR, Fu P and Lan HY:
Smad7 protects against chronic aristolochic acid nephropathy in
mice. Oncotarget. 6:11930–11944. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen HY, Huang XR, Wang W, Li JH, Heuchel
RL, Chung AC and Lan HY: The protective role of Smad7 in diabetic
kidney disease: Mechanism and therapeutic potential. Diabetes.
60:590–601. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rubio-Navarro A, Sanchez-Niño MD,
Guerrero-Hue M, García-Caballero C, Gutiérrez E, Yuste C, Sevillano
Á, Praga M, Egea J, Román E, et al: Podocytes are new cellular
targets of haemoglobin-mediated renal damage. J Pathol.
244:296–310. 2018. View Article : Google Scholar : PubMed/NCBI
|
